ערך בספרים למניה: Senti Biosciences Inc (SNTI)

Senti Biosciences, Inc. (SNTI) maintains strong scientific and technical leadership that provides strategic support for institutional players. The estimated book value per share reflects current capital dynamics, with the metric holding at -0.11. While its status as a programmable cell innovator guarantees a high level of confidence, investors should consider the financial losses and the experimental nature of the Logic Gate platform.

To build a defensive portfolio, fundamental screening relies on net assets, calculated as the difference between total assets and all company liabilities per share. The current value of -0.11 for the book value per share metric reflects the financial stability of Senti Biosciences, Inc. (SNTI), whose capitalization is supported by unique AI platforms and patent protection in the field of cell therapy.